GSK3B and cervical cancer: Furthermore, post-transcriptional modifications have been identified in components that negatively regulate the pathway; for instance, in cervical cancer samples, GSK3β is inactivated by the phosphorylation of its Ser9 residue, inducing the over-activation of the Wnt signaling pathway [127].